Experiment 493035
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | THORNES,RD: DALY,L: LYNCH,G: BRESLIN,B: BROWNE,H: BROWNE,HY: CORRIGAN,T: DALY,P: EDWARDS,G: GAFFNEY E: HENLEY,J: HEALY,T: KEANE,F: LENNON,F: MC MURRAY,N: O'LOUGHLIN,S: SHINE,M: TANNER,A:. (1994). TREATMENT WITH COUMARIN TO PREVENT OR DELAY RECCURRENCE OF MALIGNANT MELANOMA.. 120() |
| Amount utilized | |
| Compound isolated | |
| Disease | 13 PATIENTS WITH HIGH-RISK MELANOMA WERE STUDIED. THE COUMARIN WAS GIVEN DAILY FOR 2 YEARS AFTER SURGERY. TO DATE THERE ARE 4 RECURRENCES IN THE COUMARIN-TREATED GROUP OF 13 PATIENTS. |
| Dose amount | 50.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |